Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus

European Journal of Clinical Investigation

Volumn 27, Issue 6, 1997, Pages 484-490

  Maxwell, S R J ^a,d   Thomason, H ^b   Sandler, D ^e   Leguen, C ^b   Baxter, M A ^a   Thorpe, G H G ^b   Jones, A F ^c   Barnett, A H ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e NONE

Author keywords

Antioxidants; Atherosclerosis; Diabetes mellitus; Free radicals; Urate; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; URATE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SCAVENGING SYSTEM; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0030797118     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1390687.x     Document Type: Article

References (53)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of 31. Diabetologia 1978;14:363-70.
2. Jarrett RJ, McCartney P, Ken H. The Bedford Survey: 10-year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary artery disease in borderline diabetes. Diabetologia 1982;22:79-84.
3. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-56.
4. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes and aging. Free Radicals Biol Med 1991;10:339-52.
5. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
6. Oberley LW. Free radicals and diabetes. Free Radicals Biol Med 1988;5:113-24.
7. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
8. Rice-Evans C, Bruckdorfer KR. Free radicals, lipoproteins and cardiovascular dysfunction. Mol Aspects Med 1992;13:1-111.
9. Barnett AH. Pathogenesis of diabetic microangiopathy: an overview. Am J Med 1991;90(suppl. 6A):67-73.
10. Jennings PE, Barnett AH. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabetic Med 1988;5:111-17.
11. Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN. Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 1992;93:237-44.
12. 2 generation and lipid peroxidation during oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP. Biochim Biophys Acta 1990;1043:27-33.
13. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J 1993;291:529-35.
14. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981;25:373-8.
15. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. BMJ 1989;298:281-4.
16. Jones AF, Jennings PE, Wakefield A, Winkles JW, Lunec J, Barnett AH. The fluorescence of serum proteins in diabetic patients with and without retinopathy. Diabetic Med 1988;5:547-51.
17. Arai K, Iizuka S, Tada Y, Oikawa K, Taniguchi N. Increase in the glycosylated form of erythrocyte Cu-Zn-SOD in diabetes and the close association of non-enzymatic glycosylation with enzyme activity. Biochim Biophys Acta 1987;924:292-6.
18. Collier A, Small M. The role of the polyol pathway in diabetes mellitus. Br J Hospital Med 1991;45:38-40.
19. Stocker R, Frei B. Endogenous antioxidant defences in human blood plasma. In: Sies H, ed. Oxidative stress, oxidants and antioxidants. London: Academic Press, 1991.
20. Illing A, Gray C, Lawrence R. Blood glutathione and non-glucose substances in diabetes. Biochem J 1951;48:637-40.
21. Som S, Basu D, Mukherjee S et al. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981;30:572-7.
22. Herman J, Medalie J, Golbourt U. Diabetes, prediabetes and uricaemia. Diabetologia 1976;12:47-52.
23. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996;90:255-60.
24. Wardle EN. Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 1994;23:135-9.
25. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Med 1992;9:297-9.
26. Standing SJ, Taylor RP. Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods. Ann Clin Biochem 1992;29:494-505.
27. Gochman N, Schmitz JM. Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 1971;17:1154-9.
28. Whitehead TP, Thorpe GHG, Maxwell SRJ. An enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992;266:265-77.
29. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
30. Nagy E, Degrell I. Determination of ascorbic acid and dehydroascorbic acid in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. J Chromatogr Biomed Appl 1989;497:276-81.
31. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959;82:70-7.
32. Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987;924:408-19.
33. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994;43:1010-14.
34. Erdberg AS, Boner G, van Dyk DJ, Carel R. Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron 1992;60:134-7.
35. Ishihara M, Shinoda T, Yamada T. Co-occurrence of hypercalciuria and hypouricaemia in type 2 diabetic patients. Diabetic Med 1989;6:406-11.
36. Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A, Serum urate, serum glucose and diabetes. Ann Clin Biochem 1992;29:159-61.
37. Tuomiletho J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 1988;127:321-36.
38. Olukoga AO, Erasmus RT, Akinlade KS, Okesina AB, Alanamu AA, Abu EA. Plasma urate in diabetes: relationship to glycaemia, glucose disposal, microvascular complications and the variations following oral glucose. Diabetes Res Clin Pract 1991;14:99-105.
39. Grootveld M, Halliwell B. Measurement of allantoin and uric acid in human body fluids. Biochem J 1987;243:803-8.
40. Frei B, Stocker R, Ames BN. Antioxidant defences and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988;85:9748-52.
41. Vatassery GT, Smith WE, Quach HT. Ascorbic acid, glutathione and synthetic antioxidants prevent the oxidation of vitamin E in platelets. Lipids 1989;24:1043-7.
42. Stankova L, Riddle M, Larned J et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 1984;33:347-53.
43. Sinclair AJ, Girling AJ, Gray L, LeGuen C, Lunec J, Barnett AH. Disturbed handling of ascorbic acid in diabetic patients with and without diabetic microangiopathy during high dose ascorbate supplementation. Diabetologia 1991;34:171-5.
44. Jennings PE, Chirico S, Jones AF et al. Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res 1987;6:151-4.
45. Collier A, Wilson R, Bradley H, Thompson JA, Small M. Free radical activity in type 2 diabetes. Diabetic Med 1990;7:27-30.
46. Bigley R, Wirth M, Layman D, Riddle M, Stankova L. Interaction between glucose and dehydroascorbate transport in human neutrophils and fibroblasts. Diabetes 1983;32:545-8.
47. Chen MS, Hutchinson ML, Pecoraro RE, Lee WYL, Labbe RF. Hyperglycaemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983;32:1078-81.
48. Basu TK, Tze WJ, Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 1989;50:329-31.
49. Krempf M, Ranganathan S, Ritz P, Morin M, Charbonnel B. Plasma vitamin A and vitamin E in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) adult diabetic patients. Int J Vitamin Nutr Res 1991;61:38-42.
50. Kokoglu E, Ulakoglu E. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1991;14:175-81.
51. Havivi E, Bar On H, Reshef A, Stein P, Raz I. Vitamins and trace metal status in non-insulin-dependent diabetes mellitus. Int J Vitamin Nutr Res 1991;61:328-33.
52. Hunt JV, Bottoms MA, Mitchinson MJ. Ascorbic acid oxidation: a potential cause of elevated severity of atherosclerosis in diabetes mellitus? FEBS Lett 1992;311:161-4.
53. Cutler P. Deferoxamine therapy in high-ferritin diabetes. Diabetes 1989;38:1207-10.